ConvaTec

From Wikipedia, the free encyclopedia
Jump to: navigation, search
ConvaTec
Privately held; owned by Nordic Capital and Avista Capital Partners
Industry Medical Devices
Founded Created as a division of E.R. Squibb & Sons, Inc., in 1978; established as stand-alone company in 2008
Key people
Paul Moraviec, CEO
Products Wound and skin care; ostomy care; continence and critical care; infusion devices
Revenue US$ 1.7B (2013)[1]
Number of employees
8,000+[1]
Website www.convatec.com

ConvaTec is a global medical products and technologies company, offering products and services in the areas of wound and skin care; ostomy care; continence and critical care; and infusion devices. ConvaTec has over 8,000 employees, with eleven manufacturing sites in eight countries, and does business in more than 100 countries. The company has $1.7B in annual sales and is owned by Nordic Capital and Avista Capital Partners.[1]

History:

1978 – ConvaTec created as a division of E.R. Squibb & Sons, Inc. (now Bristol-Myers Squibb)
2008 – ConvaTec acquired by Nordic Capital and Avista Capital Partners
2008 – ConvaTec acquires Unomedical
2012 – ConvaTec acquires 180 Medical
2015 – ConvaTec wins UK Court of Appeal ruling that rewrites the laws of mathematics in the patent context, holding the number one no longer has singular properties, but exists on a scale of 0.5 - 1.49[2]

External links[edit]

  1. ^ a b c "ConvaTec Reports Strong Financial Results for Fiscal Year 2013". Retrieved 23 May 2014. 
  2. ^ http://www.independent.co.uk/news/science/what-exactly-does-one-mean-court-of-appeal-passes-judgement-on-thorny-mathematical-issue-10350568.html